semaglutide derived from Spotlight on the Mechanism of Action of PDB-101: Diabetes Mellitus: Diabetes Mellitus:

GLP-1 medications, initially developed to manage type 2 diabetes, have gained recognition as effective tools for weight loss

Through its unique mechanism of action as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, as well as its impressive results in clinical trials, tirzepatide has the potential to completely transform the current approach to treating obesity

Available in 1.5 mg, 14 mg, and more

Eric Topol, a physician and writer who is widely recognized both as a leading researcher and a public voice on medicine and health

Longmont, CO

It will initially be available via private prescription, with NHS use still under NICE review.